PCM
PROK icon

Prelude Capital Management’s ProKidney PROK Stock Holding History

Prelude Capital Management’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.7K Buy
+12,107
New +$25.7K ﹤0.01% 1160
2022
Q1 		– Sell
-61,432
Closed -$608K – 2140
2021
Q4 		$608K Hold
61,432
– – 0.02% 891
2021
Q3 		$602K Buy
+61,432
New +$605K 0.02% 799

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Prelude Capital Management's PROK Position: Q1 2026 in Review

Prelude Capital Management opened a new position in ProKidney (PROK) in Q1 2026: 12,107 shares worth $21.7K. The stake represents ﹤0.01% of the portfolio and ranks #1160 among its holdings. This is a return to the name: Prelude Capital Management previously reported a position in PROK as recently as Q4 2021.

Prelude Capital Management first reported a position in PROK in Q3 2021 and has held it in 3 quarters since. The position peaked at $608K in Q4 2021. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Prelude Capital Management held 12,107 shares of ProKidney worth $21.7K as of Q1 2026.
  • ProKidney was a new Prelude Capital Management position in Q1 2026.
  • ProKidney made up ﹤0.01% of Prelude Capital Management's portfolio in Q1 2026, its #1160 holding.
  • Prelude Capital Management first reported a position in ProKidney in Q3 2021 and has held it in 3 quarters since.
  • Prelude Capital Management's ProKidney position peaked at $608K in Q4 2021.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.